Center

The Hepatitis Insulin Center, founded in November 2014, is Asia's first embodied hepatic insulin-integrated medical center and is the national standard clinical demonstration base for primary liver cancer, a unit of the China Research Hospital Association accredited the National Academy of Hepatological Surgery. The center is composed of related sub-disciplines such as hepatochology, hepatocholaic pancreatology, liver transplantation, hepatocholaic oncology comprehensive diagnosis, hepatocholaic intervention therapy, pediatric hepatitis diagnosis, hepatocholaic severity monitoring room, and other relevant sub-disciplines to provide precise medical and multidisciplinary diagnostic models for patients with hepatocholaic disease (see one-stop services), systematic diagnosis and complete process management.